アミノ酸代謝障害治療市場：治療、適応症、エンドユーザー別-2024～2030年の世界予測

アミノ酸代謝障害治療市場規模は2023年に7億9,690万米ドルと推定され、2024年には8億5,117万米ドルに達し、CAGR 7.31%で2030年には13億641万米ドルに達すると予測されています。

アミノ酸代謝障害治療には、体内でアミノ酸を適切に処理できない状態を管理・治療するための介入が含まれます。アミノ酸はタンパク質のコンポーネントであり、様々な身体機能に不可欠です。このような障害が起こると、体内にアミノ酸やその副生成物が蓄積し、毒性を発揮して様々な健康問題につながる可能性があります。遺伝性疾患の有病率が上昇していることが、アミノ酸代謝障害治療の必要性を高めています。遺伝性疾患に対する意識の高まりと、多くの国々で義務化された新生児スクリーニングプログラムが、アミノ酸代謝障害の早期発見につながり、アミノ酸代謝障害に関連した迅速な治療の必要性を促進しています。低所得国では治療費が高く、認知度も低いため、市場成長の妨げとなっています。症状をよりよく管理し、寿命を延ばす、より効果的で的を絞った治療の開発につながる研究への注目の高まりは、市場成長の機会を生み出すと期待されています。

地域別洞察

南北アメリカでは、アミノ酸代謝を含む希少代謝疾患の診断と治療をサポートする強固な医療インフラが整備されています。遺伝子試験と新生児スクリーニングの治療進歩により早期発見率が大幅に向上し、タイムリーな治療介入につながっています。市場は、強力な規制の枠組みや、これらの疾患の治療法開発に携わる大手製薬企業の存在によって支えられています。この地域の認知度と医療支出は比較的高く、市場の成長に寄与しています。アジア太平洋は、特に中国、日本、インドなどの国々で医療セグメントが大きく成長しています。アミノ酸代謝障害に対する意識が高まっており、それに伴い治療ソリューションに対する需要も高まっています。欧州は、確立された医療制度、広範な新生児スクリーニングプログラム、希少疾病用医薬品に対する強力な規制支援によって、アミノ酸代謝異常症の治療市場に関してこの地域でリードしています。一方、中東・アフリカは、医療インフラとアクセスに国によって大きな格差があり、混在した様相を呈しています。所得の高い中東諸国では医療施設が充実している国もあるが、アフリカ諸国では限られた資源や専門的な医療の欠如に関連する課題に直面することが多く、これらの地域では治療市場の成長を阻害する可能性があります。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは、アミノ酸代謝障害治療市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront（F）、Pathfinder（P）、Niche（N）、Vital（V）に分類されます。

市場シェア分析

市場シェア分析は、アミノ酸代謝障害治療市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界市場で確固たる足場を築こうとする組織にとって不可欠です。企業は、アミノ酸代謝障害治療市場における現在の立ち位置を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブ概要

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • アミノ酸代謝障害の診断例が増加,
    • 希少代謝疾患に対処するための強化された支援規制政策
  • 抑制要因
    • 治療費が高額で患者のアクセスが制限される
  • 機会
    • 強化された診断ツールと遺伝子試験技術の開発
    • アミノ酸代謝障害の新たな治療法の発見を目指した継続的な調査
  • 課題
    • アミノ酸代謝障害治療の製品開発の複雑さ
• 市場セグメンテーション分析
  • 治療：体内の余分なアミノ酸を除去するための薬剤の使用が増加
  • エンドユーザー：アミノ酸代謝障害の診断と治療のための病院やクリニックを通じたアミノ酸代謝障害治療のアクセス性の向上
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 アミノ酸代謝障害治療市場：治療別

• イントロダクション
• 遺伝子治療
• 肝臓移植
• 薬剤治療
• 補充

第7章 アミノ酸代謝障害治療市場：適応症別

• イントロダクション
• メープルシロップ尿症
• フェニルケトン尿症

第8章 アミノ酸代謝障害治療市場：エンドユーザー別

• イントロダクション
• 外来手術センター
• 病院・クリニック

第9章 南北アメリカのアミノ酸代謝障害治療市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のアミノ酸代謝障害治療市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのアミノ酸代謝障害治療市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • PTC TherapeuticsがSSIEM 2023でフェニルケトン尿症治療の新たな進歩を展示
• 戦略分析と提言

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET DYNAMICS
• FIGURE 7. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY GENE THERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY LIVER TRANSPLANT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY LIVER TRANSPLANT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY SUPPLEMENTATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY SUPPLEMENTATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY MAPLE SYRUP URINE DISEASE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY MAPLE SYRUP URINE DISEASE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY PHENYLKETONURIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY PHENYLKETONURIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 30. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 31. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 32. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 33. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 34. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 37. ARGENTINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 38. ARGENTINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 39. ARGENTINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 40. ARGENTINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 41. ARGENTINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 42. ARGENTINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 43. BRAZIL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 44. BRAZIL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 45. BRAZIL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 46. BRAZIL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 47. BRAZIL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 48. BRAZIL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 49. CANADA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 50. CANADA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 51. CANADA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 52. CANADA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 53. CANADA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 54. CANADA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 55. MEXICO AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 56. MEXICO AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 57. MEXICO AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 58. MEXICO AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 59. MEXICO AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 60. MEXICO AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 61. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 62. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 63. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 64. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 65. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 66. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 67. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 68. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 70. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 72. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 74. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 76. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 77. AUSTRALIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 78. AUSTRALIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 79. AUSTRALIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 80. AUSTRALIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 81. AUSTRALIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 82. AUSTRALIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 83. CHINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 84. CHINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 85. CHINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 86. CHINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 87. CHINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 88. CHINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 89. INDIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 90. INDIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 91. INDIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 92. INDIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 93. INDIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 94. INDIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 95. INDONESIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 96. INDONESIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 97. INDONESIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 98. INDONESIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 99. INDONESIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 100. INDONESIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 101. JAPAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 102. JAPAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 103. JAPAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 104. JAPAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 105. JAPAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 106. JAPAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 107. MALAYSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 108. MALAYSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 109. MALAYSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 110. MALAYSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 111. MALAYSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 112. MALAYSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 113. PHILIPPINES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 114. PHILIPPINES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 115. PHILIPPINES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 116. PHILIPPINES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 117. PHILIPPINES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 118. PHILIPPINES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 119. SINGAPORE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 120. SINGAPORE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 121. SINGAPORE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 122. SINGAPORE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 123. SINGAPORE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 124. SINGAPORE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 126. SOUTH KOREA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 128. SOUTH KOREA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 130. SOUTH KOREA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 131. TAIWAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 132. TAIWAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 133. TAIWAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 134. TAIWAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 135. TAIWAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 136. TAIWAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 137. THAILAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 138. THAILAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 139. THAILAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 140. THAILAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 141. THAILAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 142. THAILAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 143. VIETNAM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 144. VIETNAM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 145. VIETNAM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 146. VIETNAM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 147. VIETNAM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 148. VIETNAM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 157. DENMARK AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 158. DENMARK AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 159. DENMARK AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 160. DENMARK AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 161. DENMARK AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 162. DENMARK AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 163. EGYPT AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 164. EGYPT AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 165. EGYPT AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 166. EGYPT AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 167. EGYPT AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 168. EGYPT AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 169. FINLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 170. FINLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 171. FINLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 172. FINLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 173. FINLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 174. FINLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 175. FRANCE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 176. FRANCE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 177. FRANCE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 178. FRANCE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 179. FRANCE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 180. FRANCE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 181. GERMANY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 182. GERMANY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 183. GERMANY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 184. GERMANY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 185. GERMANY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 186. GERMANY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 187. ISRAEL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 188. ISRAEL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 189. ISRAEL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 190. ISRAEL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 191. ISRAEL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 192. ISRAEL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 193. ITALY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 194. ITALY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 195. ITALY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 196. ITALY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 197. ITALY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 198. ITALY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 199. NETHERLANDS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 200. NETHERLANDS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 201. NETHERLANDS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 202. NETHERLANDS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 203. NETHERLANDS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 204. NETHERLANDS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 205. NIGERIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 206. NIGERIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 207. NIGERIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 208. NIGERIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 209. NIGERIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 210. NIGERIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 211. NORWAY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 212. NORWAY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 213. NORWAY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 214. NORWAY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 215. NORWAY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 216. NORWAY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 217. POLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 218. POLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 219. POLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 220. POLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 221. POLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 222. POLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 223. QATAR AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 224. QATAR AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 225. QATAR AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 226. QATAR AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 227. QATAR AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 228. QATAR AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 229. RUSSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 230. RUSSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 231. RUSSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 232. RUSSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 233. RUSSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 234. RUSSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 236. SAUDI ARABIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 238. SAUDI ARABIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 240. SAUDI ARABIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 242. SOUTH AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 244. SOUTH AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 247. SPAIN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 248. SPAIN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 249. SPAIN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 250. SPAIN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 251. SPAIN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 252. SPAIN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 253. SWEDEN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 254. SWEDEN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 255. SWEDEN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 256. SWEDEN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 257. SWEDEN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 258. SWEDEN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 259. SWITZERLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 260. SWITZERLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 261. SWITZERLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 262. SWITZERLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 263. SWITZERLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 264. SWITZERLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 265. TURKEY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 266. TURKEY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 267. TURKEY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 268. TURKEY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 269. TURKEY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 270. TURKEY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
• TABLE 278. UNITED KINGDOM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 280. UNITED KINGDOM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 282. UNITED KINGDOM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 283. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 284. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

[187 Pages Report] The Amino Acid Metabolism Disorders Treatment Market size was estimated at USD 796.90 million in 2023 and expected to reach USD 851.17 million in 2024, at a CAGR 7.31% to reach USD 1,306.41 million by 2030.

Amino acid metabolism disorders treatment includes interventions used to manage and treat conditions where the body cannot properly process amino acids. Amino acids are the building blocks of proteins and are crucial for various body functions. When these disorders occur, it can lead to an accumulation of amino acids or their byproducts in the body, which can be toxic and lead to various health issues. The rising prevalence of genetic disorders is driving the need for amino acid metabolism disorders treatments. Increased awareness about genetic disorders and mandatory newborn screening programs across numerous countries have led to the early detection of amino acid metabolism disorders, which are driving the need for prompt treatment associated with amino acid metabolism disorders. The high cost of treatment and lack of awareness in low-income countries hampers market growth. Rising focus on research leads to the development of more effective and targeted treatments that manage symptoms better and extend life expectancy are expected to create opportunities for market growth.

Regional Insights

In the Americas, there is a robust healthcare infrastructure that supports the diagnosis and treatment of rare metabolic disorders, including those involving amino acid metabolism. Advances in genetic testing and newborn screening have significantly improved early detection rates, leading to timely treatment interventions. The market is supported by strong regulatory frameworks and the presence of leading pharmaceutical companies engaged in developing treatments for these disorders. Awareness and healthcare spending in this region are relatively high, contributing to the market's growth. The APAC region has seen significant growth in healthcare sectors, particularly in countries such as China, Japan, and India. Awareness about amino acid metabolism disorders is growing, and with it, the demand for treatment solutions is also rising. Europe leads within this region regarding the market for treating amino acid metabolism disorders, driven by well-established healthcare systems, widespread newborn screening programs, and strong regulatory support for orphan drugs. Conversely, the Middle East and Africa present a mixed picture with significant disparities in healthcare infrastructure and access across countries. While some Middle Eastern countries with high incomes have better healthcare facilities, African nations often face challenges related to limited resources and lack of specialized care, which can impede the growth of the treatment market in these areas.

Market Insights

• Market Dynamics

The market dynamics represent an ever-changing landscape of the Amino Acid Metabolism Disorders Treatment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • Growing number of diagnosed cases of amino acid metabolism disorders,
  • Enhanced supportive regulatory policies addressing rare metabolic disorders

• Market Restraints
  • High cost of treatment limiting patient accessibility

• Market Opportunities
  • Development of enhanced diagnostic tools and genetic testing technologies
  • Ongoing research aimed at discovering new treatments for amino acid metabolism disorders

• Market Challenges
  • Complexities in product development for amino acid metabolism disorders treatment
• Market Segmentation Analysis
  • Treatment: Growing usage of medications to eliminate excess amino acids from the body
  • End-User: Growing accessibility of amino acid metabolism disorders treatment through hospitals & clinics for diagnosing and treating cases of amino acid metabolism disorders

• Market Disruption Analysis
• Porter's Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Amino Acid Metabolism Disorders Treatment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Amino Acid Metabolism Disorders Treatment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

PTC Therapeutics to Showcase New Advances in Phenylketonuria Treatment at SSIEM 2023

PTC Therapeutics, Inc. is set to present significant findings from its APHENITY clinical trial at the Society for the Study of Inborn Errors of Metabolism (SSIEM),l. The company revealed Phase 3 results of the APHENITY trial, which focused on the oral medication Sepiapterin for Phenylketonuria (PKU) management. These findings indicate sustained control of mean blood phenylalanine levels and increased protein intake among patients treated with Sepiapterin. Moreover, PTC will also discuss its ongoing research into aromatic l-amino acid decarboxylase (AADC) deficiency through various platforms at the event. [Published On: 2023-08-28]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Amino Acid Metabolism Disorders Treatment Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Amino Acid Metabolism Disorders Treatment Market, highlighting leading vendors and their innovative profiles. These include Abeona Therapeutics Inc., Alnylam Pharmaceuticals, Inc., American Gene Technologies Inc., Amgen Inc., AnGes, Inc., Astellas Gene Therapies, Beacon Therapeutics Limited, Biogen Inc., Cellectis SA, Editas Medicine, Inc., F. Hoffmann-La Roche Ltd, Ionis Pharmaceuticals, Inc., Merck KGaA, Mustang Bio, Inc., Novartis AG, and Pfizer Inc..

Market Segmentation & Coverage

This research report categorizes the Amino Acid Metabolism Disorders Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Treatment
  • Gene Therapy
  • Liver Transplant
  • Medication
  • Supplementation

• Indication
  • Maple Syrup Urine Disease
  • Phenylketonuria

• End-User
  • Ambulatory Surgery Centers
  • Hospitals & Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing number of diagnosed cases of amino acid metabolism disorders,
    • 5.1.1.2. Enhanced supportive regulatory policies addressing rare metabolic disorders
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of treatment limiting patient accessibility
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of enhanced diagnostic tools and genetic testing technologies
    • 5.1.3.2. Ongoing research aimed at discovering new treatments for amino acid metabolism disorders
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities in product development for amino acid metabolism disorders treatment
• 5.2. Market Segmentation Analysis
  • 5.2.1. Treatment: Growing usage of medications to eliminate excess amino acids from the body
  • 5.2.2. End-User: Growing accessibility of amino acid metabolism disorders treatment through hospitals & clinics for diagnosing and treating cases of amino acid metabolism disorders
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Amino Acid Metabolism Disorders Treatment Market, by Treatment

• 6.1. Introduction
• 6.2. Gene Therapy
• 6.3. Liver Transplant
• 6.4. Medication
• 6.5. Supplementation

7. Amino Acid Metabolism Disorders Treatment Market, by Indication

• 7.1. Introduction
• 7.2. Maple Syrup Urine Disease
• 7.3. Phenylketonuria

8. Amino Acid Metabolism Disorders Treatment Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centers
• 8.3. Hospitals & Clinics

9. Americas Amino Acid Metabolism Disorders Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Amino Acid Metabolism Disorders Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Amino Acid Metabolism Disorders Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. PTC Therapeutics to Showcase New Advances in Phenylketonuria Treatment at SSIEM 2023
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio